Elmo’s Wellness Check; Med Schools Overlook Training on Suicide; Religious Trauma

Elmo’s wellness check on X opened up a tidal wave of mental health despair on the social media platform. (NBC News)

In a randomized trial of women with prenatal depression, administration of the sedative dexmedetomidine early in the postpartum period significantly reduced the incidence of postpartum depression. (JAMA Network Open)

Medical schools don’t do enough to address the issue of suicide, including how to assess and identify suicidal patients, several healthcare academicians said. (Washington Post)

More than one in 10 people ages 5 to 24 years — accounting for 293 million people globally — had a diagnosable mental disorder in 2019, and 1.2% had a substance use disorder. (JAMA Psychiatry)

The FDA cleared Magstim’s transcranial magnetic stimulation system, the Horizon 3.0 with StimGuide Pro, to treat patients diagnosed with depressive or obsessive-compulsive conditions, the company announced.

In other FDA news, the agency announced a consumer-level recall of one lot of dextroamphetamine (Zenzedi) tablets, a drug indicated for ADHD and narcolepsy, after a pharmacist reported finding an antihistamine in the bottle instead of dextroamphetamine.

This man would rather live on the street than take antipsychotic medication. (New York Times)

Use of alcohol, cannabis, and nicotine among high schoolers each showed dose-dependent associations with worse psychiatric symptoms. (JAMA Pediatrics)

Researchers are studying whether keto diets can help treat serious mental illness. (NPR)

People with obsessive-compulsive disorder had an 82% higher risk of all-cause mortality, driven by both natural and unnatural causes, compared with those unaffected. (The BMJ)

Some psychiatrists want to classify religious trauma, an experience common to millions of LGBTQ Americans, as a mental disorder. (NBC News)

Please enable JavaScript to view the

comments powered by Disqus.